- Home
- USAC vs CNTA Comparison
USAC vs CNTA Comparison
Compare USAC & CNTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAC
- CNTA
- Stock Information
- Founded
- USAC 1998
- CNTA 2020
- Country
- USAC United States
- CNTA United Kingdom
- Employees
- USAC N/A
- CNTA N/A
- Industry
- USAC Natural Gas Distribution
- CNTA Biotechnology: Pharmaceutical Preparations
- Sector
- USAC Utilities
- CNTA Health Care
- Exchange
- USAC Nasdaq
- CNTA Nasdaq
- Market Cap
- USAC 2.6B
- CNTA 2.3B
- IPO Year
- USAC N/A
- CNTA 2021
- Fundamental
- Price
- USAC $22.39
- CNTA $17.60
- Analyst Decision
- USAC Hold
- CNTA Strong Buy
- Analyst Count
- USAC 4
- CNTA 7
- Target Price
- USAC $26.00
- CNTA $23.71
- AVG Volume (30 Days)
- USAC 237.9K
- CNTA 688.3K
- Earning Date
- USAC 02-11-2025
- CNTA 11-12-2024
- Dividend Yield
- USAC 9.38%
- CNTA N/A
- EPS Growth
- USAC 271.81
- CNTA N/A
- EPS
- USAC 0.56
- CNTA N/A
- Revenue
- USAC $929,606,000.00
- CNTA $6,853,000.00
- Revenue This Year
- USAC $14.26
- CNTA N/A
- Revenue Next Year
- USAC $6.23
- CNTA N/A
- P/E Ratio
- USAC $39.79
- CNTA N/A
- Revenue Growth
- USAC 14.59
- CNTA N/A
- 52 Week Low
- USAC $21.06
- CNTA $6.65
- 52 Week High
- USAC $28.47
- CNTA $18.97
- Technical
- Relative Strength Index (RSI)
- USAC 38.66
- CNTA 54.64
- Support Level
- USAC $22.72
- CNTA $15.88
- Resistance Level
- USAC $23.98
- CNTA $17.34
- Average True Range (ATR)
- USAC 0.52
- CNTA 0.92
- MACD
- USAC -0.15
- CNTA -0.10
- Stochastic Oscillator
- USAC 10.82
- CNTA 55.66
About USAC USA Compression Partners LP Common Units Representing Limited Partner Interests
USA Compression Partners LP provides compression services in the United States in terms of total compression fleet horsepower to customers relating to infrastructure applications, including both allowing for the processing and transportation of natural gas through the domestic pipeline system and enhancing crude oil production through artificial lift processes. It engineers, designs, operates, services, and repairs its compression units and maintains related support inventory and equipment. The company provides compression services in several shale plays throughout the U.S., including the Utica, Marcellus, Permian Basin, Delaware Basin, Eagle Ford, and others.
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include 1) SerpinPC for Hemophilia A, B, 2) LB101 for Solid Tumors, 3) ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders, 4) MGX292 Pulmonary Arterial Hypertension (PAH) and 5) Undisclosed for Solid Tumors.